1. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

   • Stephen B. Edge
   • Carolyn C. Compton

   Healthcare Policy and Outcomes 24 February 2010 Pages: 1471 - 1474

2. 2010 TNM Staging System for Cutaneous Melanoma…and Beyond

   • Jeffrey E. Gershenwald
   • Seng-jaw Soong
   • On behalf of the American Joint Committee on Cancer (AJCC) Melanoma Staging Committee

   Melanomas 19 March 2010 Pages: 1475 - 1477

3. Do Practice Patterns Reflect Practice Guidelines?

   • Tina W. F. Yen
   • Douglas B. Evans

   Healthcare Policy and Outcomes 16 March 2010 Pages: 1478 - 1480

4. Are Radical Compartmental Resections for Retroperitoneal Sarcomas Justified?

   • Chandrajit P. Raut
   • Carol J. Swallow

   Bone and Soft Tissue Sarcomas 17 April 2010 Pages: 1481 - 1484

5. When is Age More Than Just a Number?

   • Kathleen Diehl
   • Lisa A. Newman

   Breast Oncology 17 April 2010 Pages: 1485 - 1486

6. Age does not Preclude an Esophagectomy…If Only it were that Simple

   • Mark B. Orringer

   Thoracic Oncology 09 March 2010 Pages: 1487 - 1489

7. Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?

   • Babita Panigrahi
   • Sanziana A. Roman
   • Julie Ann Sosa

   Healthcare Policy and Outcomes 12 March 2010 Pages: 1490 - 1498

   

8. Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case–Control Study

   • Roy F. Chemaly
   • Ray Y. Hachem
   • Issam I. Raad

   Healthcare Policy and Outcomes 03 February 2010 Pages: 1499 - 1506

   

9. Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control

   • Sylvie Bonvalot
   • Rosalba Miceli
   • Alessandro Gronchi

   Bone and Soft Tissue Sarcomas 15 April 2010 Pages: 1507 - 1514

   

10. Proton-Beam, Intensity-Modulated, and/or Intraoperative Electron Radiation Therapy Combined with Aggressive Anterior Surgical Resection for Retroperitoneal Sarcomas

    • Sam S. Yoon
    • Yen-Lin Chen
    • Thomas F. DeLaney

    Bone and Soft Tissue Sarcomas 12 February 2010 Pages: 1515 - 1529

    

11. Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution Experience

    • Fatima Laki
    • Youlia M. Kirova
    • Remy J. Salmon

    Breast Oncology 23 February 2010 Pages: 1530 - 1538

    

12. Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery

    • Maria T. Sandri
    • Laura Zorzino
    • Franco Nolè

    Breast Oncology 05 February 2010 Pages: 1539 - 1545

13. Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors

    • Katrin Hoffmann
    • Clemens Franz
    • Peter Schemmer

    Breast Oncology 09 February 2010 Pages: 1546 - 1554

    

14. Prognostic Significance of c-erbB-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases

    • Jinggui Chen
    • Qingguo Li
    • Guangfa Zhao

    Hepatobiliary Tumors 13 January 2010 Pages: 1555 - 1563

    

15. Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics

    • Wenjiao Zeng
    • Annette S. H. Gouw
    • Koert P. de Jong

    Hepatobiliary Tumors Open access 20 January 2010 Pages: 1564 - 1571

    

16. Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival

    • B. B. Pultrum
    • D. J. Bosch
    • J. Th. M. Plukker

    Gastrointestinal Oncology Open access 24 February 2010 Pages: 1572 - 1580

    

17. Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity

    • Selwyn O. Rogers Jr.
    • Stacy W. Gray
    • Nancy L. Keating

    Thoracic Oncology 17 February 2010 Pages: 1581 - 1588

    

18. Effect of Age on Surgical Outcomes of Extended Gastrectomy With D2 Lymph Node Dissection in Gastric Carcinoma: Prospective Cohort Study

    • Oh Jeong
    • Young Kyu Park
    • Young Jin Kim

    Gastrointestinal Oncology 23 January 2010 Pages: 1589 - 1596

19. Risk Factors for Lymph Node Metastasis from Gastric Cancers with Submucosal Invasion

    • Yusuke Tajima
    • Masahiko Murakami
    • Takashi Kato

    Gastrointestinal Oncology 04 February 2010 Pages: 1597 - 1604

    

20. Laparoscopic Total Gastrectomy and D2 Lymphadenectomy

    • Giovanni Dapri
    • Jacques Himpens
    • Guy-Bernard Cadière

    Gastrointestinal Oncology 03 March 2010 Pages: 1605 - 1605

21. Body Mass Index does not Affect Postoperative Morbidity and Oncologic Outcomes of Total Mesorectal Excision for Rectal Adenocarcinoma

    • Nikiforos Ballian
    • Brett Yamane
    • Gregory D. Kennedy

    Colorectal Cancer 15 January 2010 Pages: 1606 - 1613

    

22. Multicentric Study on Robotic Tumor-Specific Mesorectal Excision for the Treatment of Rectal Cancer

    • Alessio Pigazzi
    • Fabrizio Luca
    • Jeong-Heum Baek

    Colorectal Cancer 20 January 2010 Pages: 1614 - 1620

    

23. Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors

    • Massimo Falconi
    • Alessandro Zerbi
    • Paolo Pederzoli

    Pancreatic Tumors 17 February 2010 Pages: 1621 - 1627

24. New Operative Surgical Concept of Two Fascial Layers Enveloping the Recurrent Laryngeal Nerve

    • Jonathan W. Serpell

    Endocrine Tumors 09 February 2010 Pages: 1628 - 1636

    

25. Prophylactic Lymphadenectomy of Neck Level II in Clinically Node-Positive Papillary Thyroid Carcinoma

    • Bon Seok Koo
    • Sung-Tae Seo
    • Young Chang Lim

    Endocrine Tumors 10 February 2010 Pages: 1637 - 1641

26. Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease

    • Pauline Wimberger
    • Michael Wehling
    • Andreas du Bois

    Gynecologic Oncology 18 February 2010 Pages: 1642 - 1648

    

27. Increased Use of Percutaneous Technique for Totally Implantable Venous Access Devices. Is It Real Progress? A 27-Year Comprehensive Review on Early Complications

    • Isidoro Di Carlo
    • Elia Pulvirenti
    • Adriana Toro

    Medical Oncology 05 March 2010 Pages: 1649 - 1656

    

28. Utility of FDG PET/CT and Brain MRI in Melanoma Patients with Increased Serum S-100B Level During Follow-up

    • Tjeerd S. Aukema
    • Renato A. Valdés Olmos
    • Omgo E. Nieweg

    Melanomas 12 February 2010 Pages: 1657 - 1661

    

29. Conditional Survival After Surgical Treatment of Melanoma: An Analysis of the Surveillance, Epidemiology, and End Results Database

    • Natasha M. Rueth
    • Shawn S. Groth
    • Elizabeth B. Habermann

    Melanomas 18 February 2010 Pages: 1662 - 1668

    

30. Skin-Sparing Mastectomy and Immediate Breast Reconstruction in the Management of Locally Recurrent Breast Cancer

    • A. J. Lindford
    • T. J. Meretoja
    • T. A. Jahkola

    Reconstructive Oncology 12 February 2010 Pages: 1669 - 1674

    

31. Clinical Significance of Tumor Necrosis Factor Receptor Superfamily Member 11b Polymorphism in Prostate Cancer

    • Bo-Ying Bao
    • Victor C. Lin
    • Shu-Pin Huang

    Urologic Oncology 04 March 2010 Pages: 1675 - 1681

    

32. Cervical Lymph Node Dissection for Metastatic Testicular Cancer

    • M. G. van Vledder
    • J. A. van der Hage
    • J. H. W. de Wilt

    Urologic Oncology 24 March 2010 Pages: 1682 - 1687

    

33. Chromosomal Alterations in Pure Nonneoplastic Breast Lesions: Implications for Breast Cancer Progression

    • Rachel E. Ellsworth
    • Darrell L. Ellsworth
    • Craig D. Shriver

    Translational Research and Biomarkers 27 January 2010 Pages: 1688 - 1694

    

34. Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma

    • Kai-Yuan Lin
    • Chia-Lang Fang
    • Yih-Huei Uen

    Translational Research and Biomarkers 20 January 2010 Pages: 1695 - 1702

    

35. Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma

    • Yu-Jia Chang
    • Chong-Chi Chiu
    • Ming-Te Huang

    Translational Research and Biomarkers 20 January 2010 Pages: 1703 - 1709

    

36. Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal

    • Paul H. Sugarbaker

    Thoracic Oncology 31 March 2010 Pages: 1710 - 1712

37. In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

    • D. Baratti
    • S. Kusamura
    • M. Deraco

    Gastrointestinal Oncology 31 March 2010 Pages: 1713 - 1714

38. Chemoradiotherapy in Adenocarcinoma of the Stomach or Esophagus

    • Christof Hottenrott
    • Dimosthenis Ziogas

    Gastrointestinal Oncology 26 March 2010 Pages: 1715 - 1716

39. Should Chemoradiotherapy Be Used in Node-Negative Esophageal or Gastric Adenocarcinoma?

    • Naveenraj L. Solomon
    • Leonidas G. Koniaris

    Gastrointestinal Oncology 09 March 2010 Pages: 1717 - 1717

40. Does Metastatic Lymph Node Ratio Really Suit for Prognostic Prediction of the D1 Lymphadenectomy?

    • Jingyu Deng
    • Han Liang

    Gastrointestinal Oncology 16 April 2010 Pages: 1718 - 1718

41. In Reply: Does Metastatic Lymph Node Ratio Really Suit for Prognostic Prediction of the D1 Lymphadenectomy?

    • Ugwuji N. Maduekwe
    • Sam S. Yoon

    Gastrointestinal Oncology 14 April 2010 Pages: 1719 - 1719

42. HER-2-Negative Breast Cancer Limitations and Next-Generation Sequencing Technology Promises

    • Georgios Baltogiannis
    • Christos Katsios
    • Dimitrios H. Roukos

    Breast Oncology 03 March 2010 Pages: 1720 - 1720